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IVH – the rise (and fall) of the surfactant 
dose?
To the Editor: The incidence (or not) of intraventricular 
haemorrhage (IVH) in infants receiving surfactant remains 
controversial. Moreover, it is well known that the incidence of 
IVH, adjusted for known risk factors, varies across neonatal 
intensive care units (NICUs) in any country.1
Given that a trend towards an increase in overall IVH 
incidence with natural surfactant was noted in the meta-
analysis by Soll,2 an important question arises: Could a recent 
trend in higher concentrations/doses of natural surfactant 
lead to an increase in IVH? It is not suggested that there is 
a consistent association between surfactant treatment and 
IVH, but this is an interesting consideration. As surfactant 
treatment has consistently been shown to lower mortality, it is 
extremely important to ensure that this is not at the expense of 
increased survival of infants brain damaged by haemorrhage 
or ischaemia.3 Infants who present with respiratory distress 
syndrome (RDS) are extremely vulnerable, and are precisely 
the infants most at risk of cerebral lesions.
This relevant question is applicable in South Africa and 
internationally, with the proposal for the inclusion of surfactant 
in the WHO model list of essential medicines. Since surfactant 
has been adopted into routine neonatal practice in South 
Africa, the other very important question of economic impact 
has shifted to questions regarding the specific preparations, 
number of doses, modes of administration, concomitant use of 
new technologies such as nasal continuous pulmonary airway 
pressure (nCPAP), etc. However, before stakeholders plunge 
headlong into an economic – or any other – argument, perhaps 
there is a need for greater collaboration between clinicians (and 
the pharmaceutical industry) in the reporting of recent trends, 
including adverse events in this very vulnerable group.
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